GPCR logo

Structure Therapeutics (GPCR) EV/EBITDA

EV/EBITDA:

-6.21-0.12(-1.97%)
June 23, 2025

Summary

  • As of today (June 24, 2025), GPCR EV/EBITDA is -6.21, with a fall of -0.12 (-1.97%) during the most recent trading session on June 23, 2025.
  • Over the past year, GPCR EV/EBITDA has increased by +14.71 (+70.32%).
  • GPCR EV/EBITDA is now -68.29% below its all-time high of -3.69.

Performance

GPCR EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherGPCRvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

GPCR EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday-2.0%+1.9%+1.7%
1 m1 month+11.2%-11.1%-10.0%
3 m3 months-6.2%+6.1%+5.0%
6 m6 months+40.9%-24.1%-21.8%
ytdytd+26.3%-14.9%-18.5%
1 y1 year+70.3%-53.0%-49.4%
5 y5 years---

GPCR EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-5.71-8.8%-6.99+11.2%
3 m3-month-3.69-68.3%-7.94+21.8%
6 m6-month-3.69-68.3%-10.70+42.0%
1 y1-year-3.69-68.3%-21.58+71.2%
3 y3-year-3.69-68.3%-40.09+84.5%
5 y5-year-3.69-68.3%-40.09+84.5%
alltimeall time-3.69-68.3%-40.09+84.5%

GPCR EV/EBITDA History

DateValue
2025
-6.21(-26.2%)
DateValue
2024
-8.42(-51.2%)
2023
-17.24

FAQ

  • What is Structure Therapeutics EV/EBITDA?
  • What is the all time high EV/EBITDA for Structure Therapeutics?
  • What is GPCR EV/EBITDA year-to-date change?
  • What is Structure Therapeutics EV/EBITDA year-on-year change?

What is Structure Therapeutics EV/EBITDA?

The current EV/EBITDA of GPCR is -6.21

What is the all time high EV/EBITDA for Structure Therapeutics?

Structure Therapeutics all-time high EV/EBITDA is -3.69

What is GPCR EV/EBITDA year-to-date change?

Structure Therapeutics EV/EBITDA has changed by +2.21 (+26.25%) since the beginning of the year

What is Structure Therapeutics EV/EBITDA year-on-year change?

Over the past year, GPCR EV/EBITDA has changed by +14.71 (+70.32%)
On this page